Skip to main content
. 2021 Jul 15;94(1125):20210117. doi: 10.1259/bjr.20210117

Table 3.

ESGO 2017 recommendations for contraindications for CRS

- Diffuse deep infiltration of the root of small bowel mesentery
- Diffuse carcinomatosis of the small bowel involving such large parts that resection would lead to a short bowel syndrome (remaining bowel < 1.5 m)
- Diffuse involvement/deep infiltration of:
- Stomach/duodenum
- Head or middle part of the pancreas
- Involvement of coeliac trunk, hepatic arteries, left gastric artery
- Central or multisegmental parenchymal liver metastases
- Multiple parenchymal lung metastases (preferably histologically proven)
- Non-resectable lymph nodes
- Brain metastases

CRS, cytoreductive surgery.